Baker, John E <br/><br/>
Human thrombopoietin reduces myocardial infarct size, apoptosis, and stunning following ischaemia/reperfusion in rats.  [electronic resource] 

 -  Cardiovascular research  Jan 2008 
 - 44-53 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0008-6363 
<br/><br/><label>Standard No.: </label>10.1093/cvr/cvm026  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Extracellular Signal-Regulated MAP Kinases--physiology<br/>Humans<br/>In Vitro Techniques<br/>Janus Kinase 2--physiology<br/>KATP Channels--physiology<br/>Male<br/>Myocardial Infarction--drug therapy<br/>Myocardial Reperfusion Injury--drug therapy<br/>Myocardial Stunning--drug therapy<br/>Rats<br/>Rats, Sprague-Dawley<br/>STAT3 Transcription Factor--physiology<br/>Thrombopoietin--pharmacology<br/>Time Factors